FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY

Summary by AI BETAClose X

Heights Capital Management (via CVI Investments) notified that on 12/11/2026 its total voting interest in Faron Pharmaceuticals fell to 17.34% (43,975,360 voting rights) from a prior 19.96%, comprised of 7.99% (18,215,360 votes) held as shares and 10.16% (25,760,000 votes) through financial instruments; the instruments include convertible bonds convertible into 10,080,000 votes (3.97%) maturing 08/02/2027 and 15,680,000 votes (6.18%) maturing 12/02/2028, and the change reflects acquisitions/disposals and a rebalancing of voting-rights exposure that could alter shareholder influence.

Disclaimer*

UK 100

Latest directors dealings